Sclerostin expression in the subchondral bone of patients with knee osteoarthritis.
The aim of this study was to assess the expression of β-catenin, transcription factor-4 (TCF-4) and sclerostin in the subchondral bone of patients with primary knee osteoarthritis (OA). Tibial plateau specimens from patients with OA who underwent total knee arthroplasty were classified into the early stage (n=15), intermediate stage (n=13) and late stage (n=17) groups using the Mankin score. Structural parameters, including total articular cartilage (TAC), subchondral bone plate (SCP) thickness and trabecular bone volume (BV/TV), were assessed using Image-Pro Plus 6.0 analysis software. Subsequently, β-catenin and sclerostin expression levels in subchondral bone were determined by immunohistochemistry. In addition, the mRNA and protein levels of β-catenin, TCF-4 and sclerostin were evaluated by RT-qPCR and western blot analysis, respectively. As regards the cartilage and subchondral bone structural parameters, TAC was reduced, while SCP thickness and BV/TV were increased due to OA, with significant differences observed among the different stages (all P<0.05). The results of immunohistochemistry revealed that the β-catenin levels in the intermediate- and late-stage samples were significantly increased, while the levels of sclerostin were markedly decreased compared with the values in the early-stage samples (all P<0.05). Compared with the intermediate-stage samples, the sclerostin levels were decreased, and SCP thickness and the β-catenin levels were increased in the late-stage samples (all P<0.05). The results of RT-qPCR and western blot analysis revealed that the β-catenin and TCF-4 mRNA and protein levels in the intermediate- and late-stage samples were significantly increased, while sclerostin expression was significantly decreased compared with the early-stage samples; a similar trend was observed between the intermediate- and late-stage samples (all P<0.05). Finally, the β-catenin and TCF-4 levels positively correlated with the Mankin scores, while there was a negative correlation with sclerostin expression. Our findings demonstrate that sclerostin expression is closely associated with the degree of joint damage in patients with OA, confirming its involvement in the development of OA.
Department of Orthopedics, The General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Long
L
Wu
Department of Orthopedics, The General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Haohui
H
Guo
Department of Orthopedics, The General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Kening
K
Sun
Department of Orthopedics, The General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Xin
X
Zhao
Department of Orthopedics, The General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Tao
T
Ma
Department of Orthopedics, The General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Qunhua
Q
Jin
D048868:Adaptor Proteins, Signal Transducing; D000368:Aged; D019645:Arthroplasty, Replacement, Knee; D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / Q000235:genetics / Q000378:metabolism; D019485:Bone Morphogenetic Proteins / Q000235:genetics* / Q000378:metabolism; D001842:Bone and Bones / Q000378:metabolism* / Q000473:pathology; D002358:Cartilage, Articular / Q000378:metabolism / Q000473:pathology; D005260:Female; D015870:Gene Expression; D005819:Genetic Markers / Q000235:genetics*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D020370:Osteoarthritis, Knee / Q000235:genetics* / Q000378:metabolism / Q000601:surgery; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013977:Tibia / Q000378:metabolism / Q000473:pathology; D000073940:Transcription Factor 4; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D051176:beta Catenin / Q000235:genetics / Q000378:metabolism
D048868:Adaptor Proteins, Signal Transducing; D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; D019485:Bone Morphogenetic Proteins; D005819:Genetic Markers; C422903:SOST protein, human; C532096:TCF4 protein, human; D000073940:Transcription Factor 4; D014157:Transcription Factors; D051176:beta Catenin
Bone. 2003 Mar;32(3):284-90
12667556
Knee Surg Sports Traumatol Arthrosc. 2010 Apr;18(4):419-33
20119671
Osteoarthritis Cartilage. 2004;12 Suppl A:S20-30
14698637
Calcif Tissue Int. 2010 Aug;87(2):99-107
20473488
Osteoarthritis Cartilage. 2008 Jun;16(6):638-46
18362080
J Bone Miner Res. 2012 Nov;27(11):2344-58
22729939
J Biol Chem. 2008 Feb 29;283(9):5866-75
18089564
Osteoarthritis Cartilage. 2008 Feb;16(2):137-62
18279766
J Biol Chem. 2005 May 20;280(20):19883-7
15778503
Cell Res. 2008 Feb;18(2):248-53
18212734
J Exp Med. 2004 Mar 15;199(6):805-14
15024046
Arthritis Res Ther. 2009;11(1):203
19232065
Osteoarthritis Cartilage. 2005 Nov;13(11):979-87
16243232
Phytomedicine. 2012 Aug 15;19(11):1029-34
22818895
EMBO J. 2003 Dec 1;22(23):6267-76
14633986
J Rheumatol Suppl. 2004 Apr;70:77-80
15132360
Arthritis Rheumatol. 2014 Nov;66(11):3028-39
25080367
J Dent Res. 2009 Jun;88(6):569-74
19587164
Arthritis Rheum. 2010 May;62(5):1349-60
20155832
J Biol Chem. 2005 Jul 22;280(29):26770-5
15908424
Bone. 2008 Apr;42(4):606-15
18280232
Clin Interv Aging. 2010 Nov 19;5:345-54
21228900
J Rheumatol Suppl. 1991 Feb;27:10-2
2027107
J Biol Chem. 2010 Dec 31;285(53):41614-26
20952383
Arthritis Rheum. 2004 Feb;50(2):341-4
14872473
J Bone Miner Res. 2009 Oct;24(10):1651-61
19419300
J Biol Chem. 2013 Jun 14;288(24):17552-8
23603903
FASEB J. 2005 Nov;19(13):1842-4
16123173
Ann N Y Acad Sci. 2010 Mar;1192:230-7
20392241
J Cell Sci. 2006 Apr 1;119(Pt 7):1283-96
16522681